21 March 2024 :Aker BioMarine ASA has published its annual financial statements in European Single Electronic Format (ESEF), available as an attachment to this release. Correction: New version enclosed due to an incorrect file name of the file containing the annual financial statements in European Single Electronic Format (ESEF) published yesterday at08:00 CET . For further information, please contactChristopher Robin Vinter , VP IR & Corporate Finance Mobile: +47 911 60 820 Email: Christopher.vinter@akerbiomarine.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. AboutAker BioMarine Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters ofAntarctica .Aker BioMarine is listed onOslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
Click here for more information
© Oslo Bors ASA, source